ArticleJournal of diabetes investigation2016

Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes.

Akiko Sarashina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.